Safety of pharmacoenhancers for HIV therapy

ISSN： 1751-2433

Source： Expert Review of Clinical Pharmacology, Vol.5, Iss.5, 2012-09, pp. : 557-568

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Safety, Efficacy and Pharmacokinetics of Ritonavir 400mg/Saquinavir 400mg Twice Daily plus Rifampicin Combined Therapy in HIV Patients with Tuberculosis

By Valeria Cavalcanti Rolla

Clinical Drug Investigation, Vol. 26, Iss. 8, 2006-01 ,pp. : 469-479

Adis International

Access to resources Recommend Favorite

Gene therapy for HIV infection

By Chadwick D.R. Lever A.M.

Expert Opinion on Therapeutic Patents, Vol. 8, Iss. 8, 1998-08 ,pp. : 983-990

Informa Healthcare

Access to resources Recommend Favorite

Immunological Approaches for HIV Therapy

Current Drug Targets - Infectious Disorders, Vol. 3, Iss. 2, 2003-06 ,pp. : 171-178

Bentham Science Publishers

Access to resources Recommend Favorite

Safety of hydroxyurea in the treatment of HIV infection

By Lori Franco Kelly Laurene M Foli Andrea Lisziewicz Julianna

Expert Opinion on Drug Safety, Vol. 3, Iss. 4, 2004-07 ,pp. : 279-288

Informa Healthcare

Access to resources Recommend Favorite

HIV therapy in 2014: Focus pediatric therapy

By Königs Christoph

PHARMAKON, Vol. 2, Iss. 5, 2014-09 ,pp. : 312-318

Govi-Verlag

Access to resources Recommend Favorite